Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GETTUM (Grupo Español de Tratamiento de Tumores Urológicos) is a leading Spanish non-profit scientific association dedicated to the advancement of clinical research in urological oncology. Founded in 1995, the group operates as an Academic Research Organization (ARO) that designs, promotes, and coordinates multicenter clinical trials across Spain to improve treatments for prostate, bladder, kidney, and germ cell cancers. GETTUM facilitates collaboration between medical oncologists, the pharmaceutical industry, and international research networks to bring innovative therapies to patients. The organization is also heavily involved in translational research, aiming to identify biomarkers that can personalize cancer care. Beyond clinical trials, GETTUM provides essential training and educational resources for healthcare professionals specializing in genitourinary tumors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grupo Español de Tratamiento de Tumores Urológicos.